EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,840,000 | -20.5% | 36,749 | 0.0% | 0.21% | -19.8% |
| Q2 2021 | $2,315,000 | -32.2% | 36,749 | 0.0% | 0.26% | -33.9% |
| Q1 2021 | $3,414,000 | +3.7% | 36,749 | 0.0% | 0.39% | -3.7% |
| Q4 2020 | $3,293,000 | -13.3% | 36,749 | 0.0% | 0.40% | -27.5% |
| Q3 2020 | $3,797,000 | +113.7% | 36,749 | +63.6% | 0.56% | +101.1% |
| Q2 2020 | $1,777,000 | +36.7% | 22,467 | 0.0% | 0.28% | +12.6% |
| Q1 2020 | $1,300,000 | +12900.0% | 22,467 | +10967.5% | 0.25% | +12200.0% |
| Q1 2019 | $10,000 | -16.7% | 203 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $12,000 | -55.6% | 203 | -50.1% | 0.00% | -50.0% |
| Q3 2018 | $27,000 | +28.6% | 407 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $21,000 | 0.0% | 407 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $21,000 | +10.5% | 407 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $19,000 | +18.8% | 407 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $16,000 | +14.3% | 407 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | +16.7% | 407 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $12,000 | – | 407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |